Black Friday Sale
Black Friday Sale
HomeNewscoronavirusUK to stop publishing infections data in new year for 'living with COVID' phase

UK to stop publishing infections data in new year for 'living with COVID' phase

The country's remaining COVID restrictions, including the legal requirement to self-isolate at home with symptoms, were removed earlier this year.

December 26, 2022 / 14:47 IST
Representative image

The UK health authorities said on Monday that they will stop publishing their regular COVID-19 infections modelling data in the new year because it is seen as no longer necessary as the country moves to a phase of living with the virus with the help of vaccines and medicines.

The UK Health Security Agency (UKHSA) said that it will continue to monitor COVID like other common viral illnesses such as seasonal flu. Since April this year, the data on the reproductive rate, or the R value speed at which the novel coronavirus infects people, has been published fortnightly as a monitoring tool.

During the pandemic, the R value and growth rate served as a useful and simple indicator to inform public health action and government decisions, said Dr Nick Watkins, chair of the UKHSA Epidemiology Modelling Review Group (EMRG).

Now that vaccines and therapeutics have allowed us to move to a phase where we are living with COVID-19, with surveillance scaled down but still closely monitored through a number of different indicators, the publication of this specific data is no longer necessary, he said.

We continue to monitor COVID-19 activity in a similar way to how we monitor a number of other common illnesses and diseases. All data publications are kept under constant review and this modelling data can be reintroduced promptly if needed, for example, if a new variant of concern was to be identified, he added.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The EMRG said its recent detailed review concluded that the next publication of its so-called consensus statement on COVID-19 on January 6, 2023, will be the last. The UK's COVID incidence data will continue to be accessible from the Office for National Statistics (ONS) infection survey.

The country's remaining COVID restrictions, including the legal requirement to self-isolate at home with symptoms, were removed earlier this year. Amid an expected rise in infections over the winter months, the health authorities had urged those with signs of respiratory illness to avoid mixing during the festive holiday period.

We are seeing a rise in cases and hospital admissions for both flu and COVID-19 as people continue to mix indoors this winter. Hospitalisation rates due to COVID-19 remain highest in those aged 65 and over, so it is vital that everyone who is eligible continues to come forward to accept their booster jab before the end of the year, Dr Mary Ramsay, Director of Public Health Programmes, said last week.

Both COVID-19 and flu can cause severe illness or even death for those most vulnerable in our communities, and so it is also important to avoid contact with other people if you are unwell in order to help stop infections spreading over the Christmas and new year period, she said.

 

PTI
first published: Dec 26, 2022 02:47 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347